Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014

15th Annual Drug Discovery Leaders Summit

02 Jun 2014 - 03 Jun 2014 - Geneva, Switzerland

Bookmark and Share

Attend Europe’s leading networking and discussion platform for drug discovery professionals.  

Meet 250 senior-level delegates from global pharmaceutical organisations, leading biotechs and esteemed academic institutions.

Hear 60 expert speakers discuss the pressing challenges in medicinal chemistry, compound screening, target-based discovery and innovation access.

Discuss the viability of the latest discovery trends, including phenotypic screening, epigenetic drug discovery, stem cell technology and nanoengineering.

Tailor your congress experience – attend any sessions from the following six streams:

- R&D Models For The Future

- Screening & Assays: Enabling Technologies

- Target Based Discovery

- Supporting Innovation: Data & Information Management

- Discovery Chemistry: Latest Case Studies

- Drug Design: Novel Approaches

The Summit is co-located with the 6th Annual Drug Development Congress - an executive level event focusing on predictive science and translational medicine.

The Drug Discovery Summit is Europe’s leading networking and discussion platform for pharmaceutical professionals. Attending this long-established event gives delegates the opportunity to:

Hear from and meet with the people shaping the pharmaceutical landscape. Previous attendees include: Vice President New Frontier Science Europe, Takeda; Vice President and Venture Leader, Janssen R&D; Vice President & Global Head, Reagents & Assay Development, AstraZeneca.

Discuss the latest discovery innovations, including 3D cell based assays, advances in nanoengineering and iPSCs for compound screening.

Discover collaborative solutions to discovery challenges. This summit brings together a host of experts to compare methods for utilising new screening technology, validating novel drug targets, improving lead optimisation and making better use of discovery data.

Enjoy unparalleled networking opportunities. The two-day congress format combines dedicated networking breaks, pre-organised 1-2-1 meetings and our popular drinks reception. The exhibition hall and poster presentation spaces offer a relaxed and professional environment for discussion.

Tailor the congress experience.  The six stream agenda offers industry updates for those working in discovery technology, target-based discovery, discovery information, discovery chemistry, drug design, research strategy and open innovation.

Contact Danielle Dalby to download the agenda and for attendance information on or call +44 (0)1865 248455

Further information
Scientific News
Four New Genetic Disorders Identified
Sharing of genetic data empowers discovery of new disorders in children.
Biomarker Predicting Transplant Complications May be Key to Treating Them
A protein that can be used to predict if a stem cell transplant patient will suffer severe complications may also be the key to preventing those complications, an international research team based at the Indiana University School of Medicine reported Wednesday.
Potential New Diagnosis and Therapy for Breast Cancer
Scientists at the University of York, using clinical specimens from charity Breast Cancer Now’s Tissue Bank, have conducted new research into a specific sodium channel that indicates the presence of cancer cells and affects tumour growth rates.
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos